对施拉姆的回复，L. 对“李等人。I1264M和V1347M变异与小儿神经母细胞瘤患者的临床结局显著相关，提示一种新的预后生物标志物：一项121例患者的癌症基因组研究。2021年，，2364”的评论
Reply to Schramm, L. Comment on "Li et al. Variants I1264M and V1347M Significantly Associated with Clinical Outcomes of Pediatric Neuroblastoma Patients Imply a New Prognostic Biomarker: A 121-Patient Cancer Genome Study. 2021, , 2364".
作者信息
Li Xiaoqing, Sun Lan, Stucky Andres, Tu Lingli, Cai Jin, Chen Xuelian, Wu Zhongjun, Jiang Xuhong, Li Shengwen Calvin
机构信息
Department of Oncology, The People's Hospital of Bishan District, Chongqing 402760, China.
Department of Hepatobiliary Surgery, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400042, China.
出版信息
Diagnostics (Basel). 2022 Mar 2;12(3):617. doi: 10.3390/diagnostics12030617.
Abstract
We thank Professor Laura Schramm for her comment on the history and clarification of BDP1 nomenclature, her contribution to gene cloning [...].
摘要
我们感谢劳拉·施拉姆教授对BDP1命名法的历史及阐释所做的评论，以及她对基因克隆所做的贡献[...]。
Zotero 插件